intelGenx Receives FDA Approval | MindMed’s 18MC On Clinical Hold

Spexis to host business update conference call on October 9, 2023 – Biotech Investments

Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST Spexis to host

October 7, 2023

Aldeyra’s dry eye drug gets a rejection from the FDA

The FDA handed down a complete response letter to Aldeyra Therapeutics for its dry eye disease drug reproxalap, following months of speculation about whether the

November 28, 2023

‘Missed opportunities’: Why a U.K. government plan to disclose financial ties between pharma and docs may fall short

Earlier this month, the U.K. government issued a proposal to gather information and opinions about payments that drug and device makers give to the medical

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.